IRIS
PENDE, ALDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.122
Totale 12.122
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.122
Totale 12.122
Salva come PNG Salva come JPEG
Città #
Genova 9.560
Rapallo 1.236
Genoa 985
Vado Ligure 290
Bordighera 51
Totale 12.122
Salva come PNG Salva come JPEG
Nome #
Lipoproteins, stroke and statins. 177
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 157
Characterization of the binding of the RNA-binding protein AUF1 to the human AT1 receptor mRNA. 154
Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. 146
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways. 145
Angiotensin II receptor antagonists in acute coronary syndromes. 142
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. 138
Plasma dopamine response to sympathetic activation in man: a biphasic pattern. 135
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability 133
Inflammation in the pathophysiology of essential hypertension. 132
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis 132
Role of Neutrophils in Atherogenesis: an Update 131
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 131
HPLC with electrochemical detection of catecholamines in human plasma, a mini-review. 130
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. 130
Blunted response of serum aldosterone to metoclopramide in the male elderly 128
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques. 127
Prevalence of erectile dysfunction in a cohort of Italian hypertensive subjects 127
Carotid atherosclerotic plaque stenosis: the stabilizing role of statins. 125
Serum PCSK9 levels predict the occurrence of acute coronary syndromes in patients with severe carotid artery stenosis 125
Circadian variations of autologous mixed lymphocyte reactions and endogenous cortisol. 125
Inflammation Is a Key Pathophysiological Feature of Metabolic Syndrome. 124
Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis 124
Anti-inflammatory approaches to reduce acute cardiovascular events: not only benefits. 123
Evidence for interactions between HLA system class I and beta-adrenergic receptors in human mononuclear leukocytes. 121
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 121
Free and sulfoconjugated catecholamines in normotensive uremic patients: effects of hemodialysis. 120
Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis 118
Morphine-induced TSH release in normal and hypothyroid subjects. 117
Update on the evidence of statin treatment to reduce plaque vulnerability. 117
Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages 117
Correlation between Progetto Cuore risk score and early cardiovascular damage in never treated subjects 115
Clorhexidine prevents hypoclorous acid-induced inactivation of alpha1-antitrypsin. 115
Classical and new renin-angiotensin signalling in atherosclerosis. 113
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis 113
Inflammatory cardiovascular risk biomarkers: update on novelties and limitations. 113
Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy. 111
Purification and characterization of b-adrenergic receptor mRNA-binding proteins. 110
Anti-ApoA-1 auto-antibodies increase cardiovascular vulnerability. 110
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 109
Yohimbine effects on blood pressure and plasma catecholamines in human hypertension 108
Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling. 108
Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk 108
Resistin exerts a beneficial role in atherosclerotic plaque inflammation by inhibiting neutrophil migration 106
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies. 104
Evaluation of pituitary-thyroid function and prolactin secretion in healthy aged subjects. 102
Neutrophil migration towards C5a and CXCL8 is abrogated by non-steroidal anti-inflammatory drugs (NSAIDs) via the inhibition of different pathways. 102
Cardiovascular prevention: Can we do any better? 102
Anti-apoliprotein A-1 autoantibodies are active mediators of atherosclerotic plaque vulnerability. 102
Agonist-mediated destabilization of human b1-adrenergic receptor mRNA: role of the 3’ untranslated region. 101
Carotid ultrasonography in the assessment of cardiovascular risk 101
Simultaneous measurement of plasma catecholamine (norepinephrine, epinephrine and dopamine) and free N-methyl dopamine (epinine) levels, by HPLC with electrochemical detection. 100
Editorial: is ischemic stroke an inflammatory disease? 98
Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrence 98
Epinine kinetics and plasma catecholamine changes following oral administration of the prodrug ibopamine in patients with chronic heart failure. 97
Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial 97
Renin-Angiotensin antagonists: therapeutic effects beyond blood pressure control? 95
Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial 95
Measurement of conjugated catecholamines in human plasma. A low cost HPLC ECD method. 93
Myocardial-directed overexpression of the human b1-adrenergic receptor in transgenic mice. 93
Recombinant tissue plasminogen activator induces neutrophil degranulation activating PI3K/Akt- and ERK1/2-mediated pathways. 93
Effects of the H2-receptor antagonist ranitidine on anterior pituitary hormone secretion in man. 93
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 93
Regulation of the mRNA-binding protein AUF1 by activation of the b-adrenergic receptor signal transduction pathway. 92
Preliminary characterization of a transgenic mouse overexpressing the human b1-adrenergic receptor. 91
Effects of blood pressure control in cardiovascular prevention 91
Intraindividual variation of beta2-adrenergic receptors on mononuclear leukocytes and their relationships with endogenous plasma catecholamines in man. 89
Identification and intracellular localization of RNA-binding proteins involved in the modulation of the hAT1 receptor mRNA stability. 89
Evaluation of the effects induced by four opiate drugs, with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men. 87
Differential binding of p37AUF1 to beta-adrenergic receptor mRNAs. 87
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial 87
Effect of clonidine on gonadotropin secretion in normal men. 86
Evidence for adrenergic mediation of the effect of morphine on LH secretion in normal men. 86
Regulation of p37AUF1, an mRNA binding protein, in human ventricular myocardium. 85
Effects of rosuvastatin on atrial fibrillation occurrence: Ancillary results of the GISSI-HF trial 85
Adrenergic receptors: relevance to myocardial signal transduction in heart failure. 84
Syndrome of inappropriate antidiuretic hormone secretion and Ibuprofen, a rare association to be considered: role of tolvaptan. 83
Evaluation of some aspects of growth hormone regulation in aging. 83
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 83
Reversed-phase HPLC separation of plasma norepinephrine, epinephrine, and dopamine with three-electrode coulimetric detection. 82
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study 82
Correlation between intrinsic mRNA stability and the affinity of AUF1 (hnRNPD) and HuR for A+U-rich mRNAs. 80
Norepinephrine-induced plasma dopamine decrease in man: pharmacological evidence of the involvement of alpha2-adrenoceptors 80
Is the carotid plaque rupture a pivotal event in stroke pathogenesis? Update on the role of the intraplaque inflammatory processes 80
ß-adrenergic receptor mediated regulation of p37AUF1, an mRNA binding protein, in DDT1-MF2 cells. 79
The 3’ untranslated region of the human beta1-adrenergic receptor is necessary but not sufficient for agonist-mediated destabilization. 78
Pituitary hormone secretion after inhibition of l-aromatic aminoacid decarboxylase. 78
Effects of Interferon alpha 2-a on catecholamines and lymphocyte beta2-adrenoceptors in healthy humans. 78
Regular Wine Consumption in Chronic Heart Failure: Impact on Outcomes, Quality of Life, and Circulating Biomarkers 78
Neuroendocrine effects of Interferon alpha 2-a in healthy human subjects. 76
Editorial: inhibition of the Renin-Angiotensin-aldosterone system: how to obtain this. 76
Interactions between HLA system and beta-adrenergic receptors in human lymphocytes. 75
Effects of opioid substances on cAMP response to the beta-adrenergic agonist isoproterenol in human mononuclear leukocytes 75
Treatment with oxaprozin reduces neutrophil migration in response to C5a and CXCL8 via the inhibition of the PI3K/Akt pathway. 74
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure 74
Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Heart Failure trial 74
Characterization of RNA-binding proteins possibly involved in modulating human AT 1 receptor mRNA stability. 74
Alpha-adrenergic control of TSH secretion in man. 72
The cannabinoid receptor type 2 is down-regulated in downstream portions of human carotid plaques. 72
Immune and endocrine effects of a thymic extract in healthy human subjects. 72
Totale 10.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.148
article - articoli 32.618
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.530
Totale 68.296
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.320 0 0 0 321 350 405 539 249 305 599 425 127
2020/20211.030 51 111 73 118 63 73 46 93 112 138 58 94
2021/20221.579 61 97 75 223 70 149 69 368 72 149 57 189
2022/20231.489 144 79 24 163 236 298 2 102 275 4 132 30
2023/2024754 26 128 23 77 66 95 56 81 47 14 36 105
2024/2025328 65 173 72 18 0 0 0 0 0 0 0 0
Totale 12.389